Perlman syndrome
| Perlman syndrome | |
|---|---|
| Synonyms | Renal hamartomas, Nephroblastomatosis, Fetal gigantism |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Macrosomia, Hypotonia, Renal abnormalities, Wilms' tumor |
| Complications | N/A |
| Onset | Prenatal |
| Duration | Lifelong |
| Types | N/A |
| Causes | Genetic mutation in the DIS3L2 gene |
| Risks | Increased risk of Wilms' tumor |
| Diagnosis | Genetic testing, Ultrasound, MRI |
| Differential diagnosis | Beckwith-Wiedemann syndrome, Sotos syndrome |
| Prevention | N/A |
| Treatment | Symptomatic and supportive care |
| Medication | N/A |
| Prognosis | Poor, with high neonatal mortality |
| Frequency | Rare |
| Deaths | N/A |
Perlman syndrome is a rare genetic disorder characterized by overgrowth, distinctive facial features, and an increased risk of developing Wilms tumor, a type of kidney cancer. It is also known as renal hamartomas, nephroblastomatosis, and fetal gigantism.
Presentation[edit]
Individuals with Perlman syndrome typically present with prenatal overgrowth, which can be detected via ultrasound during pregnancy. After birth, affected individuals may exhibit macrosomia (excessive birth weight), macrocephaly (large head size), and distinctive facial features such as deep-set eyes, epicanthal folds, a broad nasal bridge, and macroglossia (enlarged tongue). Other common features include nephromegaly (enlarged kidneys), nephroblastomatosis (abnormal kidney tissue), and cryptorchidism (undescended testes) in males.
Genetics[edit]
Perlman syndrome is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected. The specific gene or genes responsible for Perlman syndrome have not been definitively identified, but it is believed to involve mutations in genes that regulate cell growth and development.
Diagnosis[edit]
Diagnosis of Perlman syndrome is based on clinical features and may be confirmed through genetic testing. Prenatal diagnosis may be possible through ultrasound findings and genetic testing if there is a known family history of the disorder.
Management[edit]
Management of Perlman syndrome involves regular monitoring for the development of Wilms tumor and other potential complications. This may include regular abdominal ultrasounds and urinalysis. Supportive care to address feeding difficulties, respiratory issues, and developmental delays may also be necessary.
Prognosis[edit]
The prognosis for individuals with Perlman syndrome varies. Some affected individuals may have a shortened lifespan due to complications such as Wilms tumor or severe nephroblastomatosis. Early detection and management of complications can improve outcomes.
See also[edit]
References[edit]
External links[edit]
-
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian